Berg, LLC   Report issue

For profit Phase 1 Phase 2
Founded: Framingham MA United States (2006)

Organization Overview

First Clinical Trial
2008
NCT00604890
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Berg, LLC